BioAmber (BIOA) Misses Q4 EPS by 5c

BioAmber (NYSE: BIOA) reported Q4 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.11 million versus the consensus estimate of $830 thousand.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Amtech Systems closes $60 million public stock offering
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c